Extracranial head and neck neoplasms: Role of imaging

Cancer Treatment and Research

Volumn 143, Issue , 2008, Pages 93-117

  Petrou, Myria ^a   Mukherji, Suresh K ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; GLOTTIS; HEAD; HEAD AND NECK TUMOR; HUMAN; METHODOLOGY; MOUTH TUMOR; NECK; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SOFT PALATE;

DIAGNOSTIC IMAGING; GLOTTIS; HEAD; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MEDICAL ONCOLOGY; MOUTH NEOPLASMS; NECK; NEOPLASM STAGING; PALATE, SOFT; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

MLCS; MLOWN;

EID: 48249126225     PISSN: 09273042     EISSN: 25098497     Source Type: Book Series    
DOI: 10.1007/978-0-387-75587-8_4     Document Type: Article

References (94)

1. Katsantonis GP, Archer CR, Rosenblum BN et al. The degree to which accuracy of preoperative staging of laryngeal carcinoma has been enhanced by computed tomography. Otolaryngol Head Neck Surg.1986; 95:52-62.
2. Charlin B, Brazeau-Lamontagne L, Guerrier B, et al. Assessment of laryngeal cancer: CT scan versus endoscopy. J Otolaryngol.1989; 18:283-8.
3. Sulfaro S, Barzan L, Querin F et al. T staging of the laryngohypopharyngeal carcinoma. A 7-year multidisciplinary experience. Arch. Otolaryngol Head Neck Surg. 1989; 115:613-20
4. Benchaou M, Lehmann W, Slosman DO et al. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Orolarygol 1996; 116:332-35.
5. Mukherji, SK, Pillsbury H, Castillo M. Imaging squamous cell carcinoma of the upper aerodi-gestive tract: What the clinicians need to know. Radiology 1997; 205:629-646.
6. Zbaren P, Becker M, Lang H. Pretherapeutic staging of hypopharyngeal carcinoma. Clinical findings, computed tomography, and magnetic resonance imaging compared with histopatho-logic evaluation. Arch Otolaryngol Head Neck Surg. 1997; 123:908-13.
7. Bruschini P, Georgetti A, Bruschini L, et al. Positron emission tomography (PET) in the staging of head and neck cancer: Comparison between PET and CT. Acta Otorhinolaryngol Ital 2003; 23:446-53.
8. Branstetter BF 4th, Blodgett TM, Zimmer LA et al. Head and neck malignancy: Is PET/CT more accurate than PET or CT alone? Radiology 2005; 234: 580-86.
9. Mukherji SK, Bradford CR. Controversies: Is there a role for positron-emission tomographic CT in the initial staging of head and neck squamous cell carcinoma? AJNR Am J Neuroradiol. 2006; 27:243-5.
10. Ng SH, Chang TC, Ko SF, et al. Nasopharyngeal Carcinoma. CT and MR assessment. Neuroradiology 1997; 39:741-6.
11. Ginsberg LE. MR imaging of perineural tumor spread. Magn. Res Imaging Clin N Am 2002; 10:511-25.
12. Gandhi D, Gujar S, Mukherji SK. Magnetic resonance imaging of perineural spread of head and neck malignancies. Top Magn Reson Imaging 2004; 15:79-85.
13. Fakhry N, Lussato D, Jacob T. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol. 2007; 264:531-8.
14. Di Martino E, Nowak B, Hassan HA et al. Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg. 2000; 126:1457-61.
15. Murukami R, Uozumi H, Hirai T et al. Impact of FDG-PET/CT Imaging on Nodal Staging for Head-And-Neck Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2007; 68:377-82.
16. Sheikholeslam-Zadeh R, Choufani G, Goldman S, et al. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers. Acta Otorhinolaryngol Belg. 2002; 56:77-82.
17. Delgado-Bolton RC, Fernandez-Perez C, Gonzalez-Mate A, et al. Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med. 2003; 44:1301-14.
18. Gutzeit A, Antoch G, Kuhl H, et al. Unknown primary tumors: Detection with dual-modality PET/CT-initial experience. Radiology 2005; 234:227-34.
19. Greene FL, Page DL, Felming ID, eds. AJCC Cancer Staging Manual. 6th ed. Philadelphia: Lippincott Raven; 2002.
20. Yousem DM, Gad K, Tufano RP. Resectability Issues with Head and Neck Cancer. AJNR Am J Neuroradiol. 2006; 27:2024-36.
21. Yousem DM, Hatabu H, Hurst RW et al. Carotid artery invasion by head and neck masses: Prediction with MR imaging. Radiology 1995; 195:715-20.
22. Hsu WC, Loevner LA, Karpati R, et al. Accuracy of magnetic resonance imaging in predicting absence of fixation of head and neck cancers to the prevertebral space. Head Neck 2005; 27:95-100.
23. Loevner LA, Ott IL, Yousem DM et al. Neoplastic fixation to the prevertebral compartment by squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 1998; 170:1389-94.
24. Wang JC, Takashima S, Takayama F, et al. Tracheal invasion by thyroid carcinoma: Prediction using MR imaging. AJR Am J Roentgenol 2001; 177:929-36.
25. Roychowdhury S, Loevner LA, Yousem DM et al. MR imaging for predicting neoplastic infiltration of the cervical esophagus. AJNR Am J Neuroradiol 2000; 21:1681-87.
26. Shanmugaratnam K, Chan SH, de-The G: Histopathology of nasopharyngeal carcinoma: Correlations with epidemiology, survival rates and other biological characteristics. Cancer 1979; 44:1029-44
27. Chua DTT, Sham JST, Kwong DLW, et al. Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma. Cancer 2003; 98:74-80.
28. Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma. Am J Clin Oncol 2002; 25:219-223.
29. Baujat B, Audry H, Jean Bourhis J et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiation Oncology Biol Phys 2003; 57: 481-488.
30. Langendijk JA, Leemans R, Buter J et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A meta-analysis of the published literature. J Clin Oncol 2004; 22: 4604-4612.
31. Ma BBY, Chan ATC. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer 2005; 103: 22-31.
32. Sham JS, Wei WI, Zong YS et al. Detection of subclinical nasopharyngeal carcinoma by fiberoptic endoscopy and multiple biopsies. Lancet 1990; 335:371-4.
33. Hsu MM, Young YH, Lin KL. Eustachian tube function of patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 1995; 104: 453-5.
34. Sham JS, Wei WI, Lau SK et al. Serous otitis media and paranasopharyngeal extension of nasopharyngeal carcinoma. Head Neck 1992; 14:19-23.
35. Sham JS, Cheung YK, Choy D, et al. Nasopharyngeal carcinoma: CT evaluation of patterns of tumor spread. AJNR Am J Neuroradiol 1991;12:265-70.
36. Chong VF, Fan YF, Toh KH et al. MRI and CT features of nasopharyngeal carcinoma with maxillary sinus involvement. Australas Radiol 1995; 39:2-9
37. Chong VF, Fan YF. Maxillary nerve involvement in nasopharyngeal carcinoma. AJR Am J Roentgenol 1996; 167:1309-12
38. Chong VF, Fan YF, Mukherji SK. Carcinoma of the nasopharynx. Semin Ulrtrasound CT MR 1998; 19: 449-62.
39. Chong VF, Fan YF, Mukherji SK. Malignancies of the nasopharynx and the skull base. In Oncologic Imaging (2nd ed) Bragg DG, Rubin P, Hricak H (Eds). Philadelphia W.B. Saunders 2002; 202-231.
40. Chong VF, Fan YF, Khoo JB. MRI features of cervical nodal necrosis in metastatic disease. Clin Radiol 1996; 51:103-9.
41. Sham JS, Choy D, Wei WI. Nasopharyngeal carcinoma: Orderly neck node spread. Int J Radiat Oncol Biol Phys 1990; 19:929-33.
42. Chong VF, Fan YF, Khoo JB. Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Eur J Radiol 1995; 21:100-5.
43. Hollinshead WH: Textbook of Anatomy. Hagerstown, MD, Harper & Row, 928-948, 1974.
44. Mukherji SK, Castillo M. Normal cross-sectional anatomy of the nasopharynx, oropharynx and oral cavity. Neuroimaging Clin N Am 1998; 8:211-8.
45. Stambuck HE, Karimi S, Lee N, et al. Oral cavity and oropharynx tumors. Radiol Clin North Am. 2007;45:1-20
46. Million RA, Cassisi NJ, Mancuso AA: Oral Cavity. In Million RR, Cassisi NJ (eds): Management of Head and Neck Cancer: A multidisciplinary approach. Philadelphia, JB Lippincott, 599-626, 1994.
47. Wang CC. Radiation Therapy for head and neck neoplasms. 3rd edition. New York: Wiley-Liss; 1997.
48. Sessions DG, Spector GJ, Lenox J, et al. Analysis of treatment results for oral tongue cancer. Laryngoscope 2002;112: 616-25.
49. O'Brien CJ, Adams JR, McNeil EB et al. Influence of bone invasion and extent of mandibular resection on local control of cancers of the oral cavity and oropharynx. Int J Oral Maxillofac Surg. 2003; 32: 492-7.
50. Spiro R.H., Huvos A.G., Wong G.Y., et al: Predictive value of tumor thickness in squa-mous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986; 152: 345-350.
51. Mukherji SK, Isaacs DL, Creager A et al. CT detection of mandibular invasion by squamous cell carcinoma of the oral cavity. AJR Am J Roentgenol. 2001; 177:237-43.
52. Mukherji SK, Weeks S, Castillo M. Squamous cell carcinomas that arise in the oral cavity and tongue base: Can CT help predict perineural or vascular invasion? Radiology 1996; 198:157-62.
53. Genden EM, Rinardo A, Jacobson A et al. Management of mandibular invasion: When is a marginal mandibulectomy appropriate? Oral Oncol 2005; 41:776-82.
54. Mukherji SK, Fatterpekar G, Chong VF. Malignancies of the oral cavity, oropharynx and hypopharynx. In Oncologic Imaging (2nd ed) Bragg DG, Rubin P, Hricak H (Eds). Philadelphia W.B. Saunders 2002; 202-231.
55. Weber AL, Romo L, Hashmi S. Malignant tumors of the oral cavity and oropharynx:clinical, pathologic and radiologic evaluation. Neuroimag Clin N Am 2003;13: 443-464.
56. Ginsberg LE, DeMonte F. Imaging of perineural tumor spread from palatal carcinoma. AJNR Am J Neuroradiol 1998;22: 1417-22.
57. Million RA, Cassisi NJ, Mancuso AA et al: Oropharynx. In Million RR, Cassisi NJ (eds): Management of Head and Neck Cancer: A multidisciplinary approach. Philadelphia, JB Lippincott, 599-626, 1994.
58. Mendenhall WM, Morris CG, Amdur RJ et al. Definitive radiotherapy for tonsillar squamous cell carcinoma.Am J Clin Oncol. 2006;29: 290-7.
59. Shirazi HA, Sivanandan R, Goode R, et al. Advanced-staged tonsillar squamous carcinoma: Organ preservation versus surgical management of the primary site. Head Neck 2006; 28: 587-94.
60. Poulsen M, Porceddu SV, Kingsley PA. Locally advanced tonsillar squamous cell carcinoma: Treatment approach revisited. Laryngoscope 2007; 117: 45-50.
61. Merati AL, Rieder AA. Normal endoscopic anatomy of the pharynx and larynx. Am J Med. 2003; 115 Suppl 3A:10S-14S.
62. Saleh E, Mancuso AA, Stringer S. Relative roles of computed tomography and endoscopy for determining the inferior extent of pyriform sinus carcinoma: Correlative histopathologic study. Head Neck. 1993; 15: 44-52.
63. Wenig BL, Ziffra KL, Mafee MF, et al. MR imaging of squamous cell carcinoma of the larynx and hypopharynx. Otolaryngol Clin North Am. 1995;28: 609-619.
64. Becker M. Larynx and hypopharynx. Radiol Clin North Am. 1998; 36:891-920.
65. Schmalfuss IM. Imaging of the hypopharynx and cervical esophagus. Magn Reson Imaging Clin N Am. 2002; 10: 495-509.
66. Pameijer FA, Mancuso AA, Mendenhall WM, et al. Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck. 1998; 20:159-168.
67. Keberle M, Hoppe F, Dotzel S et al. Tumor volume as determined by computed tomography predicts local control in hypopharyngeal squamous cell carcinoma treated with primary surgery. Eur Radiol 2004;14:286-91.
68. Million RR. Pharyngeal walls, pyriform sinus, postcricoid pharynx. In: Million RR, ed. Management of head and neck cancer. Philadelphia: JB Lippincott 1994:502-532.
69. Yousem DM, Tufano RP. Laryngeal Imaging. Magn Reson Imaging Clin N Am. 2002; 10: 451-465.
70. Mukherji SK, Becker M. Carcinoma of the larynx. In Oncologic Imaging (2nd ed) Bragg DG, Rubin P, Hricak H (Eds). Philadelphia W.B. Saunders 2002; 233-61.
71. Zbaren P, Becker M, Laeng H. Staging of laryngeal cancer: Endoscopy, computed tomography and magnetic resonance imaging versus histopathology. Eur Arch Otolaryngol 1997; 254:117-122.
72. Gallo A, Mocetti O, De Vincentiis M, et al. Neoplastic infiltration of laryngeal cartilages: Histocytochemical study. Laryngoscope 1992; 102: 891-5.
73. Freeman DE, Mancuso AA, Parsons JT, et al. Irradiation alone for supraglottic larynx carcinoma: Can CT findings predict treatment results?. Int J Radiat Oncol Biol Phys. 1990;19: 485-490.
74. Mukherji SK, Mancuso AA, Mendenhall Wm et al. Can pretreatment CT predict local control of T2 glottic carcinomas treated with radiation therapy alone? AJNR Am J Neuroradiol 1995; 16:655-662.
75. Pameijer FA, Mancuso AA, Mendenhall WM, et al. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 1997; 37: 1011-1021.
76. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer 1995; 75(suppl1): 147-53.
77. Loevner LA. Paranasal Sinus Neoplasms. In Oncologic Imaging (2nd ed) Bragg DG, Rubin P, Hricak H (Eds). Philadelphia W.B. Saunders 2002; 160-81.
78. Curtin HD, Williams R, Johnson J. CT of perineural tumor extension: Pterygopalatine fossa. AJNR Am J Neuroradiol. 1984; 5:731-737.
79. Kraus DH, Lanzieri CF, Wanamaker JR, et al. Complementary use of computed tomography and magnetic resonance imaging in assessing skull base lesions. Laryngoscope. 1992; 102:623-629.
80. Maroldi R, Farina D, Battaglia D et al. MR of malignant nasosinusal neoplasms: Frequently asked questions. Eur J Radiol 1997; 24:181-190.
81. Van Tuyl R, Gissack GS. Prognostic factors in craniofacial surgery. Laryngoscope 1991; 101:240-44.
82. Osguthorpe JD, Patel S. Craniofacial approaches to sinus malignancy. Otolaryngol Clin North Am 1995; 28:1239-1257.
83. Perry C, Levine PA, Williamson BR, et al. Preservation of the eye in paranasal sinus cancer surgery. Arch Otolaryngol Head Neck Surg. 1988; 114: 632-634.
84. McCary WS, Levine PA. Management of the eye in the treatment of sinonasal cancers. Otolaryngol Clin North Am. 1995; 28: 1231-1238'
85. Hermans R, De Vuysere S, Marchal G. Squamous cell carcinoma of the sinonasal cavities [Review] Semin Ultrasound CT MR 1999; 20:150
86. Loevner LA, Sonners AI. Imaging of neoplasms of paranasal sinuses. Magn Reson Imaging Clin N Am. 2002;10:467-93.
87. Eisen MD, Yousem DM, Montone KT, et al. Use of preoperative MR to predict dural, perineural, and venous sinus invasion of skull base tumors. AJNR Am J Neuroradiol 1996; 17:1937-45.
88. Eisen MD, Yousem DM, Loevner LA et al. Preoperative imaging to predict orbital invasion by tumor. Head Neck 2000; 22:456-62.
89. Som PM, Shapiro MD, Biller Hf et al. Sinonasal tumors and inflammatory tissues: Differentiation with MR imaging. Radiology 1988; 167:803-8.
90. Hasso AN, Lambert D. Magnetic resonance imaging of the paranasal sinuses and nasal cavities.Top Magn Reson Imaging 1994; 6:209-23.
91. Daffner RH, Lupetin AR, Dash N et al. MRI in the detection of malignant infiltration of bone marrow. AJR Am J Roentgenol 1986;146: 353-8.
92. Kimura F, Kim KS, Friedman H, et al. MR imaging of the normal and abnormal clivus. AJR Am J Roentgenol 1990; 11:1015-21
93. Ricci C, Cova M, Kang YS et al. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology 1990; 177: 83-8.
94. Poulton TB, Murphy WD, Duek JL et al. Bone marrow reconversion in adults who are smokers: MR imaging findings. AJR Am J Roentgenol 1993; 161:1217-21.